Lobbying disclosures · Lobbying report
MDGL: third_quarter 2026 lobbying report
Advocacy related to prescription drug access and pricing.
Follow MDGL- Became public
- Oct 18, 2026, 2:08 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 6:19 AM EST
Why this is connected
Exact legal-name match: MADRIGAL PHARMACEUTICALS, INC. (https://www.sec.gov/Archives/edgar/data/1157601/).
Reported lobbying amounts
Income: $120,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/4f158a41-add4-436e-a086-54fd405a136a/","filing_uuid":"4f158a41-add4-436e-a086-54fd405a136a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/4f158a41-add4-436e-a086-54fd405a136a/print/","filing_document_content_type":"text/html","income":"120000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Sara Nuvy","dt_posted":"2026-10-18T14:08:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Thirteenth St, NW","registrant_address_2":"Suite 250 S","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104288,"url":"https://lda.gov/api/v1/registrants/401104288/","house_registrant_id":null,"name":"BALLARD PARTNERS","description":"Government relations and advocacy services","address_1":"601 Thirteenth St, NW","address_2":"Suite 250 S","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SARA NUVY","contact_telephone":"+1 202-800-5620","dt_updated":"2026-10-22T11:27:44.246261-04:00"},"client":{"id":70096,"url":"https://lda.gov/api/v1/clients/70096/","client_id":70096,"name":"MADRIGAL PHARMACEUTICALS, INC.","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-11-19"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Advocacy related to prescription drug access and pricing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65360,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BALLARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148820,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ANWAY","suffix":null,"suffix_display":null},"covered_position":"LA to Senator Pat Roberts 2006-2010","new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in MDGL
These disclosures provide context. Their presence does not establish a link between a trader and the event.
DisclosedTradeAmount
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Madrigal Pharmaceuticals MDGL
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.